Oral bacterial enzymes

Oral bacterial enzymes are a heterogeneous group of proteins produced by the diverse microbiota of the human oral cavity. These enzymes include hydrolases, glycosyl hydrolases (GHs), polysaccharide lyases (PLs), proteases, lipases, and others, each contributing to the metabolism of dietary and host-derived substrates within oral biofilms. Classically, key genera in the oral microbiome (e.g., Streptococcus, Bacteroides, Fusobacterium, Capnocytophaga, Porphyromonas, Actinomyces, Prevotella) express strain-specific sets of enzymes that drive dental plaque formation, carbohydrate fermentation (contributing to caries), and host tissue degradation (implicated in periodontitis and other infections)[3][6]. Some, such as bacterial beta-lactamases and proteases, play important roles in antibiotic resistance and immune evasion[2][7]. While these enzymes are not a single "therapeutic target," their activities collectively represent important determinants of oral and systemic health and are under investigation as biomarkers and therapeutic targets in the context of oral infectious and inflammatory diseases[3][6]. Key points: - “Oral bacterial enzymes” is not a specific canonical entity or single target, but a descriptive category[3][6][4]. - The enzymes are central to microbial metabolism, biofilm formation, and oral health and disease[3][6]. - Their inhibition or modulation is a potential therapeutic strategy for oral disease, but broad targeting risks ecological disruption of the oral microbiome and resistance issues[6]. This entry is best treated as a non-canonical, overly broad term rather than a distinct molecular target as defined in classic pharmacology or drug discovery contexts.

Other names

oral microbial enzymesoral microbiome enzymesoral bacterial hydrolasesoral CAZymes (carbohydrate-active enzymes)oral beta-lactamasesoral proteasesoral glycosidases

Antibiotics: inhibition or modification of bacterial viability often targets or is influenced by these enzymes Enzyme inhibitors: direct inhibition of enzymatic activity (e.g., protease/beta-lactamase inhibition) Antiseptics: broad inhibition/killing of oral bacteria, reducing enzyme burden